Balsalazide Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Balsalazide Market covers analysis By Dosage Form (Table, Capsule); Distribution Channel (Hospitals, Retail Channel, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Apr 2024

  • Report Code : TIPRE00021881
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET INTRODUCTION

Ulcerative colitis is a disease that causes swelling and sores in the lining of the colon and rectum. Balsalazide is used to treat it. Balsalazide is anti-inflammatory medication.

MARKET DYNAMICS

The Balsalazide market is driving due to the rising prevalence of ulcerative colitis. However, side effects of drugs is expected to hamper the growth of the global Balsalazide market.

MARKET SCOPE

The "Balsalazide Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Balsalazide market with detailed market segmentation by distribution channel and dosage form. The Balsalazide market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Balsalazide market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Balsalazide market is segmented on the basis of dosage form and distribution channel. Based on dosage form, the market is segmented as table and capsule. On the basis of distribution channel, the market is categorized as hospitals, retail channel, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Balsalazide market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Balsalazide market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Balsalazide market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Balsalazide market in these regions.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Balsalazide market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Balsalazide market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Balsalazide market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Balsalazide market in these regions.

MARKET PLAYERS

The report covers key developments in the Balsalazide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Balsalazide market are anticipated to have lucrative growth opportunities in the future with the rising demand for Balsalazide in the global market. Below mentioned is the list of few companies engaged in the Balsalazide market.

The report also includes the profiles of key players in Balsalazide market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   PD-Rx Pharmaceuticals, Inc.
  •   Oceanside Pharmaceuticals
  •   AvKARE, LLC.
  •   Apotex Corp.
  •   American Health Packaging
  •   Golden State Medical Supply, Inc.
  •   Salix Pharmaceuticals, Inc
  •   Sun Pharma
  •   Intas Pharmaceuticals Ltd
  •   Torrent Pharma

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Balsalazide Market - By Dosage Form
1.3.2 Balsalazide Market - By Distribution Channel
1.3.3 Balsalazide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BALSALAZIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BALSALAZIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BALSALAZIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. BALSALAZIDE - GLOBAL MARKET OVERVIEW
6.2. BALSALAZIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BALSALAZIDE MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. TABLE
7.3.1. Overview
7.3.2. Table Market Forecast and Analysis
7.4. CAPSULE
7.4.1. Overview
7.4.2. Capsule Market Forecast and Analysis
8. BALSALAZIDE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. RETAIL CHANNEL
8.4.1. Overview
8.4.2. Retail Channel Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. BALSALAZIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Balsalazide Market Overview
9.1.2 North America Balsalazide Market Forecasts and Analysis
9.1.3 North America Balsalazide Market Forecasts and Analysis - By Dosage Form
9.1.4 North America Balsalazide Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Balsalazide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Balsalazide Market
9.1.5.1.1 United States Balsalazide Market by Dosage Form
9.1.5.1.2 United States Balsalazide Market by Distribution Channel
9.1.5.2 Canada Balsalazide Market
9.1.5.2.1 Canada Balsalazide Market by Dosage Form
9.1.5.2.2 Canada Balsalazide Market by Distribution Channel
9.1.5.3 Mexico Balsalazide Market
9.1.5.3.1 Mexico Balsalazide Market by Dosage Form
9.1.5.3.2 Mexico Balsalazide Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Balsalazide Market Overview
9.2.2 Europe Balsalazide Market Forecasts and Analysis
9.2.3 Europe Balsalazide Market Forecasts and Analysis - By Dosage Form
9.2.4 Europe Balsalazide Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Balsalazide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Balsalazide Market
9.2.5.1.1 Germany Balsalazide Market by Dosage Form
9.2.5.1.2 Germany Balsalazide Market by Distribution Channel
9.2.5.2 France Balsalazide Market
9.2.5.2.1 France Balsalazide Market by Dosage Form
9.2.5.2.2 France Balsalazide Market by Distribution Channel
9.2.5.3 Italy Balsalazide Market
9.2.5.3.1 Italy Balsalazide Market by Dosage Form
9.2.5.3.2 Italy Balsalazide Market by Distribution Channel
9.2.5.4 Spain Balsalazide Market
9.2.5.4.1 Spain Balsalazide Market by Dosage Form
9.2.5.4.2 Spain Balsalazide Market by Distribution Channel
9.2.5.5 United Kingdom Balsalazide Market
9.2.5.5.1 United Kingdom Balsalazide Market by Dosage Form
9.2.5.5.2 United Kingdom Balsalazide Market by Distribution Channel
9.2.5.6 Rest of Europe Balsalazide Market
9.2.5.6.1 Rest of Europe Balsalazide Market by Dosage Form
9.2.5.6.2 Rest of Europe Balsalazide Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Balsalazide Market Overview
9.3.2 Asia-Pacific Balsalazide Market Forecasts and Analysis
9.3.3 Asia-Pacific Balsalazide Market Forecasts and Analysis - By Dosage Form
9.3.4 Asia-Pacific Balsalazide Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Balsalazide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Balsalazide Market
9.3.5.1.1 Australia Balsalazide Market by Dosage Form
9.3.5.1.2 Australia Balsalazide Market by Distribution Channel
9.3.5.2 China Balsalazide Market
9.3.5.2.1 China Balsalazide Market by Dosage Form
9.3.5.2.2 China Balsalazide Market by Distribution Channel
9.3.5.3 India Balsalazide Market
9.3.5.3.1 India Balsalazide Market by Dosage Form
9.3.5.3.2 India Balsalazide Market by Distribution Channel
9.3.5.4 Japan Balsalazide Market
9.3.5.4.1 Japan Balsalazide Market by Dosage Form
9.3.5.4.2 Japan Balsalazide Market by Distribution Channel
9.3.5.5 South Korea Balsalazide Market
9.3.5.5.1 South Korea Balsalazide Market by Dosage Form
9.3.5.5.2 South Korea Balsalazide Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Balsalazide Market
9.3.5.6.1 Rest of Asia-Pacific Balsalazide Market by Dosage Form
9.3.5.6.2 Rest of Asia-Pacific Balsalazide Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Balsalazide Market Overview
9.4.2 Middle East and Africa Balsalazide Market Forecasts and Analysis
9.4.3 Middle East and Africa Balsalazide Market Forecasts and Analysis - By Dosage Form
9.4.4 Middle East and Africa Balsalazide Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Balsalazide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Balsalazide Market
9.4.5.1.1 South Africa Balsalazide Market by Dosage Form
9.4.5.1.2 South Africa Balsalazide Market by Distribution Channel
9.4.5.2 Saudi Arabia Balsalazide Market
9.4.5.2.1 Saudi Arabia Balsalazide Market by Dosage Form
9.4.5.2.2 Saudi Arabia Balsalazide Market by Distribution Channel
9.4.5.3 U.A.E Balsalazide Market
9.4.5.3.1 U.A.E Balsalazide Market by Dosage Form
9.4.5.3.2 U.A.E Balsalazide Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Balsalazide Market
9.4.5.4.1 Rest of Middle East and Africa Balsalazide Market by Dosage Form
9.4.5.4.2 Rest of Middle East and Africa Balsalazide Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Balsalazide Market Overview
9.5.2 South and Central America Balsalazide Market Forecasts and Analysis
9.5.3 South and Central America Balsalazide Market Forecasts and Analysis - By Dosage Form
9.5.4 South and Central America Balsalazide Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Balsalazide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Balsalazide Market
9.5.5.1.1 Brazil Balsalazide Market by Dosage Form
9.5.5.1.2 Brazil Balsalazide Market by Distribution Channel
9.5.5.2 Argentina Balsalazide Market
9.5.5.2.1 Argentina Balsalazide Market by Dosage Form
9.5.5.2.2 Argentina Balsalazide Market by Distribution Channel
9.5.5.3 Rest of South and Central America Balsalazide Market
9.5.5.3.1 Rest of South and Central America Balsalazide Market by Dosage Form
9.5.5.3.2 Rest of South and Central America Balsalazide Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BALSALAZIDE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BALSALAZIDE MARKET, KEY COMPANY PROFILES
12.1. PD-RX PHARMACEUTICALS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. OCEANSIDE PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AVKARE, LLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. APOTEX CORP.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMERICAN HEALTH PACKAGING
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GOLDEN STATE MEDICAL SUPPLY, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SALIX PHARMACEUTICALS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUN PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INTAS PHARMACEUTICALS LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TORRENT PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. PD-Rx Pharmaceuticals, Inc.
2. Oceanside Pharmaceuticals
3. AvKARE, LLC.
4. Apotex Corp.
5. American Health Packaging
6. Golden State Medical Supply, Inc.
7. Salix Pharmaceuticals, Inc.
8. Sun Pharma
9. Intas Pharmaceuticals Ltd
10. Torrent Pharma
11. LGM Pharma
12. Aristo Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Balsalazide Market